Familial breast cancer

Familial breast cancer

• Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer

  Clinical guidelines, CG164 - Issued: June 2013 This clinical guideline updates and replaces NICE clinical guideline 41. It offers evidence-based advice on the classification and care of people at risk of familial breast cancer. It also makes recommendations on genetic testing thresholds, surveillance and risk reduction and treatment strategies for people with a diagnosis of breast cancer and a family history of breast, ovarian or a related cancer. These areas are not covered by Early and locally advanced breast cancer (NICE clinical guideline 80).
  

  • Other information

    NICE Pathways

    This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
    Visit the NICE Pathway: familial breast cancer
    

    How this guidance was produced

    Background information

    • CG164 Familial breast cancer: clinical evidence review
    • CG164 Familial breast cancer: cost effectiveness evidence review
    • CG164 Familial breast cancer: needs assessment
  This page was last updated: 02 July 2013